CAMBRIDGE, Mass., July 31, 2018 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference callon Tuesday, August 7, 2018, at 4:30 p.m. ET to review its second quarter 2018 financial results and provide an update on the company.
A live webcast of the conference call can be accessed
About InfinityInfinity is an innovative biopharmaceutical company dedicated to advancing novel cancer treatments. Infinity is advancing IPI-549, a potentially transformative immuno-oncology approach that aims to reprogram tumor-associated macrophages by selectively inhibiting PI3K-gamma. A Phase 1/1b study in approximately 200 patients with advanced solid tumors is ongoing. For more information on Infinity, please refer to Infinity's website at www.infi.com.
Contact: Daniella Funaro, Stern Investor Relations, Inc.212-362-1200 or email@example.com
View original content:http://www.prnewswire.com/news-releases/infinity-announces-the-date-of-its-second-quarter-2018-financial-results-conference-call-and-webcast-300689428.html
SOURCE Infinity Pharmaceuticals, Inc.
Subscribe to our Free Newsletters!
Mastocytosis is a rare condition marked by accumulation of mast cells under the skin and various ...
Lusutrombopag is used to treat abnormally low platelet counts (thrombocytopenia) in adult patients ...
Stereotypic movement disorder (SMD) is a motor disorder, associated with neurodevelopmental ...View All